Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessTreatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes
Gastrin has been implicated in islet growth/neogenesis, and proton pump inhibitors (PPIs) have been shown to increase endogenous gastrin levels in animals and humans. Therefore, we investigated the effect of P...
-
Article
40th EASD Annual Meeting of the European Association for the Study of Diabetes